Precision Nutrition Market Projected to Garner Significant Revenues by 2029

Comments · 32 Views

Precision Nutrition Market by Technology (Metabolomics, Genomics, Transcriptomics, Proteomics), Application (Disease Management, General Health & Wellness, Weight Management), Service Type, End-Use, Supplement, and Region - Global Forecast to 2029

The global precision nutrition market is estimated at USD 6.09 billion in 2024 and is projected to reach USD 12.89 billion by 2029, at a CAGR of 16.2% from 2024 to 2029. The precision nutrition market is so fast growing because of the emergent demand by consumers for personal health solutions, genomic and microbiome research breakthroughs, and increased chronic disease prevalence. Advanced AI and data analytics innovations are also allowing for the development of customized dietary and supplement advice to make personalized nutrition more accessible, and action orientated. The market is also expanding owing to increased focus on preventive healthcare and surging numbers of at-home test kits and digital platforms. Further, rising investments in research and the adoption of precision nutrition within corporate wellness programs, healthcare strategies, and fitness initiatives are driving the market forward. With growing awareness about nutrition, which affects the overall well-being, it can be expected that the market of precision nutrition would expand further to serve the requirements of diverse consumers in a global perspective.

Precision Nutrition Market

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2370137

Genomics and Multi-Omics: The Leading Service Segment

The genomics and multi-omics segment dominate the precision nutrition market within the service type category. Leveraging technologies such as genomics, proteomics, metabolomics, and microbiomics, this segment enables personalized dietary recommendations by offering deep insights into genetic predispositions, metabolic pathways, and gut microbiome interactions. This cutting-edge approach significantly enhances the effectiveness of nutrition policies across healthcare, wellness, and food industries, driven by its widespread acceptance and integration. As consumer demand for personalized wellness continues to grow, genomics and multi-omics remain central to the precision nutrition concept.

Vitamins: The Top Segment in Supplements (2024–2029)

The vitamins segment leads the supplement category in the precision nutrition market for the forecast period of 2024–2029. Vitamins play a pivotal role in addressing individual nutritional deficiencies and promoting overall health, making them a cornerstone of personalized nutrition programs. Their popularity stems from their tailored compatibility with genetic, lifestyle, and health-specific needs. Consumers increasingly seek personalized solutions to enhance immunity, energy levels, and metabolic health, solidifying the dominance of vitamins in the market. Additionally, advancements in diagnostics, such as multi-omics technologies, have made vitamin recommendations more precise and effective.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=2370137

Europe: A Key Regional Player

Europe holds a significant share of the precision nutrition market, fueled by its advanced healthcare infrastructure, consumer awareness of tailored health solutions, and strong governmental support for genomics and nutrition research. The region boasts a robust ecosystem of biotechnology companies and academic institutions driving innovation in precision nutrition technologies, including DNA-based dieting and microbiome analysis. The rising demand for customized wellness programs and the increasing prevalence of chronic diseases further accelerate the adoption of precision nutrition solutions in Europe. Key markets such as Germany, the UK, and France are expected to remain growth hubs, bolstering the region's leadership in this sector.

Leading Precision Nutrition Companies:

The report profiles key players such as Viome Life Sciences, Inc. (US), Prenetics Global Limited (China), ZOE Limited (UK), myDNA Life Australia Pty Ltd. (Australia), 23andMe, Inc. (US), DayTwo Inc (US), Nutrigenomix (Canada), Genesis Healthcare Co. (Japan), AMILI (Singapore), and SelfDecode (US).

Comments
ADVERTISE || APPLICATION || AFFILIATE